Delivery Order SPE2DB22D9239-SPE2DB24FDH26
- Not listed
- This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award, with a ceiling value of $37,053.68, is a firm fixed-price delivery order under the DLA's SPE2DB indefinite delivery vehicle (IDV) contract, valued up to $4,999,999. Through this IDV, DMS Pharmaceutical Group will provide a wide range of pharmaceuticals, including flumazenil injection, prednisone...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) for the delivery of a wide range of pharmaceutical products and medical supplies. The award, valued at $16,961.90, is a delivery order under the DLA's SPE2DX24FENXH program, which is an indefinite delivery contract vehicle that enables DLA to issue firm fixed-price orders for various pharmaceutical items to support the recurring medical supply needs of military...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies to military and government healthcare facilities. The contract has an award value of $37,053.68 and a completion date of April 10, 2024. The contract is a delivery order under a larger indefinite delivery vehicle (IDV) contract, contract #SPE2DB, which has a ceiling value of up to...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order from the Defense Logistics Agency (DLA) valued at $4,928.68. The contract is for the delivery of a variety of pharmaceutical products, including medications and medical supplies, to support the medical needs of military health facilities globally. This order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA, contract SPE2DB-13-D-4600, which has a...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $30,691.70 firm fixed-price delivery order from the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract provides a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. DMS...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $18,318.75 firm fixed-price delivery order contract is for the supply of pharmaceutical products, including medications such as flumazenil injections, prednisone tablets, and oncology drugs, to support the recurring medical needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger $499,999,999...
- The federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $106,300.56 firm fixed-price delivery order contract is for the provision of various pharmaceutical products, including medications such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of pharmaceutical products and medical supplies. The $17,795.10 contract has a period of performance through March 14, 2024. This order is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract valued up to $4,999,999 that DMS Pharmaceutical Group holds with the DLA...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency (DLA) Medical Supply Chain program. The contract, valued at $1,512.88, covers the delivery of pharmaceutical products to support the recurring medical supply needs of military health facilities. These products include medications such as flumazenil injections, prednisone tablets, ampicillin injections, and various specialty drugs. The...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999. The contract has no set-aside designation. Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products, from common medications to specialized drugs and medical supplies, to fulfill the...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDH26Delivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) to provide a range of pharmaceutical products. The contract, valued up to $2,284.16, is a delivery order under the DLA's SPE2DB program, which is an indefinite delivery vehicle (IDV) with a ceiling of up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical Group will fulfill recurring medical supply needs of military health facilities, including items such as flumazenil injection, prednisone tablets, and contraceptive products. The contract has no set-aside designation, but DMS Pharmaceutical Group's woman-owned small business status has enabled direct awards for pharmaceutical Prime Vendor programs supporting the Department of Defense. This specific delivery order for $2,284.16 is for Fosamax 70 mg tablets, with a performance period ending on March 18, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/15/24 |